angiotensinconvert
enzym
ace
homologu
angiotensinconvert
enzym
critic
counterregulatori
enzym
reninangiotensin
system
implic
cardiac
function
renal
diseas
diabet
atherosclerosi
acut
lung
injuri
ace
catalyt
activ
chlorid
sensit
caus
presenc
chloridebind
site
ace
site
chlorid
regul
activ
also
substrat
depend
sitedirect
mutagenesi
employ
elucid
site
residu
respons
chlorid
sensit
site
residu
testicular
ace
equival
residu
found
critic
chlorid
sensit
testicular
ace
also
confirm
vital
chlorid
regul
mediat
site
addit
identifi
residu
critic
substrat
select
mutant
rel
wildtyp
possess
fourfold
greater
select
format
vasodil
angiotensin
vasoconstrictor
angiotensin
ii
enhanc
angiotensin
ii
cleavag
result
increas
v
max
compar
wildtyp
inhibit
also
found
chlorid
sensit
testicular
ace
residu
identifi
influenc
potenc
inhibitor
consequ
import
insight
chlorid
sensit
substrat
select
inhibit
testicular
ace
elucid
two
homolog
domain
nand
cdomain
contain
activ
site
tace
possess
singl
catalyt
domain
correspond
cdomain
sace
requir
chlorid
ion
hydrolysi
angiotensin
ace
long
recogn
activ
also
regul
chlorid
ion
chlorid
regul
enzym
substrat
depend
cleavag
angiotensin
ace
activ
chlorid
ion
wherea
bradykinin
cleavag
maxim
concentr
mm
increas
chlorid
concentr
valu
produc
inhibitori
effect
activ
presenc
chlorid
also
increas
hydrolysi
angiotensin
inhibit
cleavag
vasoconstrictor
angiotensin
ii
propos
chlorid
bind
induc
subtl
chang
conform
activ
site
either
facilit
hinder
substrat
bind
sace
high
level
express
kidney
extracellular
chlorid
ion
level
fluctuat
consequ
chlorid
regul
ace
could
serv
regulatori
mechan
maintain
physiolog
appropri
balanc
activ
crystal
structur
tace
show
two
chloridebind
site
present
first
site
locat
distanc
away
zinc
ion
activ
site
wherea
second
site
consider
closer
zinc
ion
ndomain
sace
shown
possess
site
enzym
three
chloridebind
site
total
chlorid
site
absent
result
substitut
tace
residu
result
project
sidechain
locat
site
consequ
bind
chlorid
ion
one
site
previou
mutagenesi
studi
sace
shown
site
residu
essenti
chlorid
sensit
residu
conserv
tace
glu
mutat
result
loss
chlorid
ion
sensit
synthet
peptid
mcaapk
dnp
mca
acetyl
dnp
serv
substrat
henc
would
appear
site
must
sole
respons
chlorid
sensit
wherea
tace
phenomenon
result
combin
effect
site
present
essenti
residu
sitemedi
regul
tace
activ
unknown
addit
although
identifi
essenti
chlorid
regul
site
sace
role
equival
tace
residu
investig
previous
studi
candid
residu
potenti
involv
chlorid
bind
site
ace
chang
sitedirect
mutagenesi
effect
chlorid
sensit
substrat
select
inhibitor
potenc
observ
pcr
mutagenesi
site
residu
tace
residu
surround
chlorid
ion
site
tace
shown
fig
tace
residu
coordin
chlorid
ion
site
conserv
residu
influenc
chlorid
bind
therefor
chlorid
sensit
enzym
activ
equival
tace
residu
also
implic
sitemedi
chlorid
sensit
close
proxim
chlorid
ion
also
lie
two
residu
upstream
known
critic
substrat
bind
site
chlorid
tace
bound
water
molecul
correspond
residu
cdomain
sace
previous
shown
mutant
serv
vital
role
chlorid
depend
equival
residu
tace
pcr
mutagenesi
employ
tace
site
residu
describ
list
tabl
order
investig
role
chlorid
sensit
tace
tripl
mutant
also
construct
determin
whether
synergist
effect
chlorid
sensit
occur
stabl
express
tace
mutant
establish
cell
shown
compar
wildtyp
form
mutant
protein
also
migrat
sdspage
appar
r
wildtyp
enzym
fig
consequ
differ
observ
activ
level
enzym
variant
attribut
signific
alter
protein
express
angiotensin
substrat
mm
nacl
physiolog
concentr
chlorid
ion
human
plasma
mutant
vari
degre
level
activ
less
wildtyp
tace
mutant
contain
site
mutat
lowest
level
activ
tace
possess
rel
activ
respect
contrast
tace
equival
variant
mutant
lowest
rel
activ
tabl
rate
angiotensin
ii
cleavag
also
record
mm
nacl
variant
tabl
physiolog
substrat
enzym
surprisingli
site
mutant
tripl
mutant
show
enhanc
level
angiotensin
ii
cleavag
compar
wildtyp
physiolog
concentr
chlorid
possess
rel
activ
respect
result
strongli
suggest
contribut
substrat
select
enzym
particularli
higher
level
activ
residu
number
tace
first
chlorid
ion
shown
green
fix
posit
rel
tace
residu
residu
subject
sitedirect
mutagenesi
shown
bold
cl
coordin
residu
shown
ital
cl
unabl
bound
site
result
sidechain
project
region
angiotensin
ii
hydrolysi
angiotensin
wherea
wildtyp
differ
observ
tabl
substrat
specif
wildtyp
tace
chlorid
sensit
follow
remov
chlorid
ion
extens
dialysi
effect
increas
chlorid
concentr
activ
wildtyp
tace
observ
fig
report
previous
angiotensin
cleavag
tace
activ
chlorid
ion
activ
profil
differ
howev
two
enzym
tace
activ
continu
increas
nacl
increas
fig
wherea
maxim
activ
obtain
approxim
mm
nacl
fig
degre
chlorid
activ
angiotensin
hydrolysi
greater
tace
increas
level
activ
record
mm
nacl
compar
mm
tace
wherea
increas
activ
occur
effect
increas
chlorid
concentr
rate
cleavag
angiotensin
ii
distinct
complex
angiotensin
fig
twofold
increas
activ
observ
nacl
increas
mm
increas
chlorid
concentr
produc
inhibitori
effect
activ
plateau
reach
mm
nacl
consequ
level
activ
mm
nacl
less
absenc
nacl
less
mm
nacl
order
observ
effect
variou
mutat
chlorid
sensit
tace
fold
differ
activ
mm
nacl
angiotensin
mm
nacl
angiotensin
ii
record
fig
concentr
chosen
allow
elucid
maxim
level
chlorid
activ
wildtyp
intriguingli
tace
show
inhibit
angiotensin
cleavag
induc
mm
nacl
correspond
fold
differ
activ
compar
differ
record
wildtyp
fig
site
site
mutat
also
show
pronounc
effect
signific
chlorid
sensit
observ
either
variant
mutant
behav
similar
manner
two
mutant
also
lack
chlorid
sensit
wildtyp
show
increas
angiotensin
cleavag
mm
nacl
variant
possess
significantli
lower
level
chlorid
activ
substrat
exhibit
increas
activ
respect
fig
show
increas
activ
chlorid
sensit
enzym
similar
variant
addit
found
lack
signific
chlorid
sensit
substrat
show
activ
absenc
chlorid
ion
angiotensin
ii
serv
substrat
promin
differ
wildtyp
observ
sever
variant
lack
signific
level
chlorid
sensit
fig
mutant
alreadi
identifi
possess
greater
level
activ
wildtyp
substrat
mm
nacl
tabl
even
pronounc
illustr
fig
absenc
chlorid
ion
greater
level
activ
wildtyp
substrat
angiotensin
chlorid
sensit
variant
angiotensin
ii
similar
kinet
paramet
angiotensin
ii
cleavag
wildtyp
variant
show
elev
level
angiotensin
ii
cleavag
decreas
level
angiotensin
cleavag
compar
wildtyp
physiolog
nacl
concentr
tabl
investig
alter
substrat
select
variant
kinet
paramet
k
v
max
wildtyp
cleavag
angiotensin
ii
mm
nacl
elucid
tabl
found
signific
differ
k
valu
two
variant
v
max
higher
catalyt
effici
v
max
k
also
greater
wildtyp
condit
data
indic
mutat
increas
angiotensin
ii
hydrolysi
enhanc
maxim
level
activ
alter
substratebind
affin
effect
site
mutat
chlorid
sensit
tace
inhibit
shown
previous
potenc
nand
cdomain
ace
inhibit
captopril
lisinopril
enalaprilat
enhanc
nacl
increas
howev
previou
report
chlorid
sensit
potenc
inhibitor
henc
doserespons
curv
obtain
inhibit
variant
inhibit
tace
variant
captopril
absenc
presenc
nacl
mm
ic
valu
deriv
doserespons
curv
show
inhibit
wildtyp
sensit
chlorid
concentr
observ
wildtyp
tace
fig
ic
valu
record
mm
nacl
lower
absenc
chlorid
ion
wildtyp
captopril
ic
valu
wildtyp
tace
decreas
mm
nacl
chlorid
sensit
inhibitor
potenc
lack
tace
fig
agreement
absenc
chlorid
sensit
angiotensin
cleavag
variant
fig
variant
ic
valu
greater
record
wildtyp
absenc
presenc
mm
nacl
respect
fig
similarli
variant
ic
valu
greater
wildtyp
absenc
presenc
mm
nacl
respect
therefor
clear
two
mutat
reduc
potenc
find
studi
provid
support
physiolog
relev
chlorid
sensit
ace
activ
confirm
increas
cl
mm
physiolog
concentr
human
plasma
increas
angiotensin
decreas
angiotensin
ii
cleavag
increas
angiotensin
cleavag
ace
would
effect
increas
local
concentr
vasoconstrictor
angiotensin
ii
decreas
cl
would
lead
opposit
scenario
reduc
local
angiotensin
ii
concentr
high
level
ace
kidney
expos
enzym
fluctuat
cl
occur
plasma
therefor
vivo
cl
sensit
may
serv
regul
local
concentr
angiotensin
peptid
particularli
kidney
thu
act
homeostat
regulatori
mechan
format
tace
mutant
sever
site
residu
critic
chlorid
sensit
activ
identifi
first
time
tace
equival
residu
coordin
chlorid
ion
site
ionic
interact
remov
interact
mutagenesi
abolish
greatli
reduc
level
chlorid
sensit
locat
close
proxim
chlorid
ion
site
lie
two
residu
upstream
known
critic
substrat
bind
mutagenesi
tace
equival
also
identifi
residu
critic
chlorid
sensit
two
enzym
site
unlik
influenc
zinc
bind
ion
tace
howev
suggest
import
stabil
complex
format
residu
subdomain
ii
involv
directli
substrat
bind
site
ace
previous
suggest
contain
mechanist
bind
chlorid
ion
bound
enzym
break
salt
bridg
cdomain
sace
facilit
movement
toward
activ
site
found
studi
tace
site
mutant
possess
signific
chlorid
sensit
predict
previou
studi
equival
sace
mutant
consequ
critic
chlorid
depend
tace
sace
xray
crystal
structur
tace
reveal
combin
water
molecul
bind
chlorid
ion
site
ionic
interact
residu
chlorid
ion
therefor
essenti
chlorid
sensit
mediat
site
although
site
chlorid
absent
variant
affect
chlorid
sensit
enzym
observ
increas
activ
twofold
less
wildtyp
angiotensin
absent
angiotensin
ii
would
thu
appear
mutat
abl
transmit
longrang
effect
chlorid
sensit
enzym
induc
site
chlorid
sensit
tace
tripl
mutant
consist
found
similar
tace
respect
suggest
greatest
influenc
chlorid
regul
activ
site
ace
inde
contain
mechanist
bind
chlorid
ion
site
residu
strongli
influenc
substrat
select
remov
posit
charg
residu
creation
mutant
produc
enzym
compar
wildtyp
show
twofold
greater
activ
substrat
angiotensin
ii
twofold
less
activ
angiotensin
physiolog
nacl
crystal
structur
reveal
topolog
chemic
environ
subsit
dictat
four
residu
expect
restrict
size
substrat
p
sidechain
therefor
mutat
probabl
alter
environ
subsit
make
favour
angiotensin
ii
hydrolysi
less
favour
angiotensin
hydrolysi
kinet
data
confirm
variant
threefold
greater
catalyt
effici
wildtyp
angiotensin
ii
result
alter
substratebind
affin
increas
v
max
variant
variant
enhanc
activ
toward
angiotensin
ii
potenti
therapeut
valu
acut
lung
injuri
mice
suffer
condit
previous
shown
markedli
improv
diseas
follow
inject
recombin
abdomen
studi
potenc
tace
inhibitor
discov
chlorid
sensit
high
cl
increas
inhibitor
potenc
believ
occur
result
facilit
inhibitor
bind
conform
chang
induc
chlorid
bind
intriguingli
contrast
find
potenc
ace
inhibitor
known
increas
rat
subject
lowsalt
diet
therefor
appar
addit
saltsensit
mechan
vivo
influenc
ace
inhibitor
potenc
overrid
chlorid
bindinginduc
alter
ace
inhibitor
potenc
observ
residu
identifi
critic
potenc
mutat
drastic
reduc
ic
valu
record
comparison
wildtyp
locat
next
subsit
mutat
hypothes
alter
environ
region
one
less
accommod
bind
approxim
dichlorobenzyl
group
unlik
directli
hinder
inhibitor
bind
probabl
explan
mutat
transmit
conform
chang
activ
site
long
distanc
make
environ
bind
less
favour
peptid
angiotensin
angiotensin
ii
mutagen
pcr
carri
ml
eppendorf
tube
reaction
volum
describ
previous
plasmid
dna
prepar
singl
coloni
fulli
sequenc
ensur
presenc
desir
point
mutat
absenc
unintend
mutat
cell
cultur
atmospher
co
dmem
grown
approxim
confluenc
petri
dish
immedi
prior
transfect
lg
plasmid
dna
cell
monolay
wash
twice
nacl
p
genejuic
transfect
reagent
use
ratio
dna
reagent
w
v
ad
petri
dish
ml
dmem
incub
h
addit
supplement
dmem
h
transfect
cell
passag
allow
grow
supplement
medium
contain
antibiot
mgaeml
cell
subject
repeat
round
select
reach
confluenc
passag
allow
continu
grow
select
medium
collect
solubl
secret
protein
cell
incub
ml
optimem
h
harvest
sampl
concentr
use
centricon
millipor
billerica
usa
kda
cutoff
filter
unit
fulllength
tace
protein
obtain
follow
medium
remov
wash
cell
three
time
nacl
p
scrape
ml
nacl
p
chlorid
activ
assay
sampl
exchang
mm
hepe
koh
ph
use
centricon
kda
cutoff
filter
unit
total
rna
isol
cell
use
rneasi
mini
kit
valencia
ca
usa
accord
manufactur
guidelin
rtpcr
carri
use
onestep
rtpcr
kit
bd
bioscienc
san
jose
ca
usa
accord
manufactur
guidelin
follow
pcr
profil
use
one
cycl
h
one
cycl
min
cycl
min
one
cycl
min
amplicon
sequenc
confirm
integr
product
process
carri
mutant
variant
protein
concentr
determin
use
bicinchonin
acid
assay
bovin
serum
albumin
standard
protein
sampl
prepar
gel
load
buffer
sigma
pool
uk
heat
min
sampl
separ
sdspage
use
method
describ
laemmli
polyacrylamid
run
gel
polyacrylamid
stack
gel
broadrang
prestain
protein
standard
run
alongsid
sampl
protein
electrophoret
transfer
poli
vinyliden
difluorid
membran
polyacrylamid
gel
membran
satur
nacl
tri
mm
tri
hcl
ph
mm
nacl
contain
w
v
nonfat
milk
h
tace
detect
membran
incub
overnight
mous
monoclon
antihuman
ace
ectodomain
igg
obtain
r
system
europ
ltd
abingdon
uk
w
v
bovin
serum
albumin
nacl
tri
contain
v
v
tween
tbst
rins
tbst
membran
wash
three
time
tbst
min
room
temperatur
membran
incub
h
room
temperatur
horseradish
peroxidiseconjug
antimous
igg
obtain
sigma
tbst
tbst
wash
repeat
visual
immunoreact
protein
chemiluminesc
use
ecl
kit
ident
method
detect
employ
except
primari
antibodi
goat
polyclon
antihuman
ectodomain
igg
obtain
r
system
secondari
antibodi
horseradish
peroxidaseconjug
antigoat
igg
obtain
sigma
activ
assay
carri
mm
hepe
buffer
ph
contain
state
concentr
nacl
final
volum
specif
activ
determin
preincub
lg
protein
either
lm
captopril
acespecif
inhibitor
nm
inhibitor
min
addit
lm
angiotensin
angiotensin
ii
reaction
carri
h
termin
heat
min
condit
ensur
product
format
linear
respect
time
amount
protein
aliquot
assay
solut
appli
c
reversephas
hplc
column
lm
particl
size
mm
intern
diamet
phenomenex
cheshir
uk
uv
detector
set
nm
separ
carri
room
temperatur
flow
rate
mlae
min
mobil
phase
consist
v
v
trifluoroacet
acid
water
mobil
phase
b
consist
v
v
trifluoroacet
acid
acetonitril
linear
gradient
b
b
min
min
final
condit
min
reequilibr
use
elut
posit
product
determin
use
pure
synthet
standard
k
v
max
valu
determin
describ
except
six
concentr
angiotensin
ii
rang
lm
incub
variou
form
tace
enzym
concentr
adjust
ensur
substrat
consum
lowest
substrat
concentr
guarante
product
format
linear
respect
time
durat
assay
k
v
max
valu
calcul
linear
regress
use
equat
v
v
max
k
ic
valu
inhibit
variant
determin
describ
previous
ic
valu
captopril
inhibit
tace
variant
determin
similar
manner
except
abzfrk
dnp
serv
substrat
